ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "psoriatic arthritis and skin"

  • Abstract Number: 697 • 2018 ACR/ARHP Annual Meeting

    Clinical Results of Patients with Peripheral Psoriatic Arthritis Not Receiving Biological Therapy in a Multidisciplinary Unit

    Clara Pérez-Velásquez1, Maria Luz Garcia Vivar2, Silvia Perez Barrio3, Eva Galindez-Agirregoikoa1, Esther Ruíz Lucea1, Ignacio Torre-Salaberri4, Olaia Fernández-Berrizbeitia1, Ana Rosa Inchaurbe Pellejero2, Juan Blanco Madrigal1, Edurne Guerrero Basterretxea2, Itziar Calvo Zorrilla2, Oihane Ibarguengoitia2, David Montero2, Natalia Rivera-García1, Maria Jesus Allande Lopez Linares1 and Iñigo Gorostiza-Hormaetxe5, 1Rheumatology, University Hospital of Basurto, Bilbao, Spain, 2Rheumatology, Rheumatology Department; Basurto University Hospital, Bilbao, Spain, 3Dermatology, University Hospital of Basurto, Bilbao, Spain, 4Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, 5Unit of Research, University Hospital of Basurto, Bilbao, Spain

    Background/Purpose: We consider multidisciplinary management necessary, especially in a subgroup of patients with Psoriatic Arthritis (PsA) for complexity, cutaneous and / or joint involvement. Despite…
  • Abstract Number: 625 • 2017 ACR/ARHP Annual Meeting

    Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials

    Atul A. Deodhar1, Kim A. Papp2, Catherine Shuler3, So Young Park3 and Tore K. Kvien4, 1Oregon Health & Science University, Portland, OR, 2K Papp Clinical Research and Probity Medical Research Inc, Waterloo, ON, Canada, 3Eli Lilly and Company, Indianapolis, IN, 4Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Rapid onset of clinical improvement is an important attribute of treatment success for patients with PsA. These analyses evaluate the speed of onset of…
  • Abstract Number: 1555 • 2017 ACR/ARHP Annual Meeting

    Treatment Changes By Joint Activity and Skin Severity in Patients with Comorbid Psa and Pso

    Philip J Mease1, Carol J. Etzel2, Jeffrey Lisse3, April W Armstrong4, William J Huster3, Sabrina Rebello2, Rhiannon Dodge2, Talia M Muram3, Sarah Al Sawah3, Mwangi J Murage3, Jeffrey D Greenberg2 and William Malatestinic3, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Corrona, LLC, Southborough, MA, 3Eli Lilly and Company, Indianapolis, IN, 4Keck School of Medicine, University of Southern California, Los Angeles, CA

    Background/Purpose: Treatment of both joint and skin symptoms is important for overall disease management of patients with psoriatic arthritis and comorbid psoriasis1,2. The objective of…
  • Abstract Number: 2532 • 2017 ACR/ARHP Annual Meeting

    The Relationship between the Degree of Skin Involvement and Joint Activity in Patients with Psa: Experience from the Corrona Registry

    Philip J Mease1, Carol J. Etzel2, Jeffrey Lisse3, April W Armstrong4, William J Huster3, Sabrina Rebello2, Rhiannon Dodge2, Talia M Muram3, Sarah Al Sawah3, Mwangi J Murage3, Jeffrey D Greenberg2 and William Malatestinic3, 1Department of Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, 2Corrona, LLC, Southborough, MA, 3Eli Lilly and Company, Indianapolis, IN, 4Keck School of Medicine, University of Southern California, Los Angeles, CA

    Background/Purpose:   Prior studies have shown an inconsistent relationship between skin and joint symptoms in patients with comorbid PsO and PsA1-3.  The objective of the…
  • Abstract Number: 2533 • 2017 ACR/ARHP Annual Meeting

    Current Psa Therapy Impacts the Relationship between the Degree of Skin Invlovment and Joint Activity

    Philip J Mease1, Carol J. Etzel2, Jeffrey Lisse3, April W Armstrong4, William J Huster3, Sabrina Rebello2, Rhiannon Dodge2, Talia M Muram3, Sarah Al Sawah3, Mwangi J Murage3, Jeffrey D Greenberg2 and William Malatestinic3, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Corrona, LLC, Southborough, MA, 3Eli Lilly and Company, Indianapolis, IN, 4Keck School of Medicine, University of Southern California, Los Angeles, CA

    Background/Purpose: Simultaneous control of joint symptoms and degree of skin involvement has been linked to improvement in health-related quality of life in patients with coexistent…
  • Abstract Number: 2700 • 2016 ACR/ARHP Annual Meeting

    The Lymphatic System: A Gatekeeper for Migration of Pathogenic T-Cells Towards Synovial Joints and Entheses in Psoriasis

    Radjesh Bisoendial1,2, Errol Prens3, Annemarie Mus2, Patrick Asmawidjaja2, Nadine Davelaar2, Arien Hofman4, Jean-Bart Jaquet4, Mieke Hazes2, Marc Kok1, Wolfgang Weninger5 and Erik Lubberts2, 1Clinical Immunology and Rheumatology, Maasstad hospital, Rotterdam, Netherlands, 2Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 3Dermatology, Erasmus University medical Center, Rotterdam, Netherlands, 4Plastic surgery, Maasstad hospital, Rotterdam, Netherlands, 5Immune imaging, The Centenary Institute, Sydney, Australia

    Background/Purpose: Psoriasis (PsO) is a common inflammatory skin disease that is characterized by acanthosis, impaired immune cell migration, and remodeling of the vascular and lymphatic…
  • Abstract Number: 2806 • 2015 ACR/ARHP Annual Meeting

    Bacterial Skin Microbiome in Psoriatic Arthritis – Pilot Data from Psoriatic Plaques on Dry Skin Sites from Patients with Psoriasis (PsC) and Psoriatic Arthritis (PsA)

    Madhura Castelino1, Stephen Eyre2, Mauro Tutino2, John Moat3, Paul Martin2, Umer Ijaz4, Christopher Quince5, Pauline Ho1, Mathew Upton6 and Anne Barton1,7, 1NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, United Kingdom, 2Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom, 3Microbiology and Virology Unit, University of Manchester, Manchester, United Kingdom, 4School of Engineering, University of Glasgow, Glasgow, United Kingdom, 5Warwick Medical School, University of Warwick, Coventry, United Kingdom, 6Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom, 7Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University Of Manchester, Manchester, United Kingdom

    Background/Purpose: In complex traits like psoriasis (PsC) and psoriatic arthritis (PsA) interactions between genetics and environmental factors are thought to result in the development of…
  • Abstract Number: 701 • 2015 ACR/ARHP Annual Meeting

    Is Skin Disease More Important to Women or Men in the Assessment of Disease Activity in Psoriatic Arthritis?

    Maqbool Sheriff1, Michel Zummer2, J Antonio Avina-Zubieta3, Proton Rahman4, Wojciech Olszynski5, Michael Starr6, Philip Baer7, Emmanouil Rampakakis8, Eliofotisti Psaradellis9, Cathy Tkaczyk10, Brendan Osborne10, Karina Maslova11, Francois Nantel12 and Allen J Lehman11, 1Nanaimo Regional General Hospital, Nanaimo, BC, Canada, 2Rheumatology, Hôpital Maisonneuve-Rosemont and University of Montreal, Montreal, QC, Canada, 3Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, 4Rheumatology, St. Clare's Mercy Hospital, St. John's, NF, Canada, 5University of Saskatchewan, Saskatoon, SK, Canada, 6Rheumatology, McGill University, Montreal, QC, Canada, 7Section on Rheumatology, Ontario Medical Association/Journal of the Canadian Rheumatology Association, Toronto, ON, Canada, 8JSS Medical Research, St-Laurent, QC, Canada, 9JSS Medical Research, Montreal, QC, Canada, 10Medical Affairs, Janssen Inc., Toronto, ON, Canada, 11Janssen Inc., Toronto, ON, Canada, 1219 Green belt Dr, Janssen Inc., Toronto, ON, Canada

    Background/Purpose: Patient global assessment of disease activity (PtGA) is a standard outcome measure used both in randomized controlled trials and in clinical practice to ascertain…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.